Back to search
FDAFDA · Food and drugs·Recall number D-0415-2025

TESTOSTERONE PELLET 200 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0122-01

Published May 14, 2025 · Recall initiated: April 28, 2025

Summary

FDA records drug Class II recall D-0415-2025, published May 14, 2025 and initiated April 28, 2025. Recalling firm: BSO LLC; Status: Ongoing; Reported quantity: 1,447 vials; Lot: Lot 20250205@6, exp 1/30/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Presence of Particulate Matter: Glass particles were found in pellet vials.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
BSO LLC
Distributor
Nationwide in the USA
Lot
Lot 20250205@6, exp 1/30/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TESTOSTERONE PELLET 200 mg (with Cholesterol </=4%), 1 Pellet for Subcutaneous Use, This is a Compounded Drug, Not for Resale, RX or Office Use Only, Belmar Select Outsources, 12860 W. Cedar Drive #211, Lakewood, CO 80228, NDC: 70168-0122-01 recalled?

Yes. FDA published recall D-0415-2025 on May 14, 2025. Reported hazard: Presence of Particulate Matter: Glass particles were found in pellet vials.

What should I do if I have this product?

Voluntary: Firm initiated · Letter